Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Argus Health
Express Scripts
UBS
Fuji
Federal Trade Commission
Deloitte
Daiichi Sankyo
Teva
Medtronic

Generated: September 25, 2018

DrugPatentWatch Database Preview

Perrigo Pharms Co Company Profile

« Back to Dashboard

What is the competitive landscape for PERRIGO PHARMS CO, and what generic and branded alternatives to PERRIGO PHARMS CO drugs are available?

PERRIGO PHARMS CO has one approved drug.



Summary for Perrigo Pharms Co
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Perrigo Pharms Co

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Perrigo Pharms Co SCOPOLAMINE scopolamine FILM, EXTENDED RELEASE;TRANSDERMAL 078830-001 Jan 30, 2015 AB RX No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Julphar
Accenture
Fuji
Moodys
Express Scripts
Dow
Deloitte
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.